Nkarta, Inc. (NKTX) income statement
NKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$1.12−0.03 (-2.61%)
Close on Nov 19, 2026Market cap $80.22MP/E –Yield 0.00%
Nkarta, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -28.9%
Financial strength
- Current ratio
- 7.98
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 105.9%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.32
- Dividend yield
- 0.00%
See a number that looks wrong?